Kelli L Hartman (K L Adeleye)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Prostate Cancer

Top Venues

Journal of dental research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Kelli L Hartman, A R Li, Y Xie, S Pochampally, D Hamilton, F Garcia-Godoy, D D Miller, Wei Li
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma. Journal of dental research (2024)
Kelli L Hartman, A R Li, Y Xie, S Pochampally, D Hamilton, F Garcia-Godoy, D D Miller, Wei Li
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma. Journal of dental research 103 (9) (2024)
Kelli L Hartman, A R Li, Y Xie, S Pochampally, D Hamilton, F Garcia-Godoy, D D Miller, Wei Li
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma. Journal of dental research 103 (9) (2024)
Kelli L Hartman, A R Li, Y Xie, S Pochampally, D Hamilton, F Garcia-Godoy, D D Miller, Wei Li
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma. Journal of dental research 103 (9) (2024)
Shanshan Deng, Raisa I Krutilina, Kelli L Hartman, Hao Chen, Deanna N Parke, Rui Wang, Sasha H Shafikhani, Dejian Ma, Pradeep B Lukka, Bernd Meibohm, Tiffany N Seagroves, Duane D Miller, Wei Li
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer. Molecular cancer therapeutics 21 (7) (2022)
Raisa I Krutilina, Kelli L Hartman, Damilola Oluwalana, Hilaire C Playa, Deanna N Parke, Hao Chen, Duane D Miller, Wei Li, Tiffany N Seagroves
Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis. Cancers 14 (21) (2022)